Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo

被引:95
作者
Hagg, T [1 ]
机构
[1] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada
基金
英国医学研究理事会;
关键词
axotomy; brain-derived neurotrophic factor; neuronal death; neurotrophic factor; neurotrophin-3; neurotrophin-4; neurotrophin-4/5; nigrostriatal; Parkinson; substantia nigra;
D O I
10.1006/exnr.1997.6684
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) promote survival of mesencephalic dopaminergic neurons in vitro and affect normal and damaged ones in vivo. Here, these neurotrophins had markedly different potencies to prevent the death of axotomized nigrostriatal dopaminergic neurons when infused close to the rostral end of the nigral nucleus of adult rats (NT-4 > BDNF > NT-3; nerve growth factor or NGF without effect). With a high dose of BDNF (30 mu g/day) complete protection was achieved in the rostral but not caudal nigral regions, consistent with its poor diffusion characteristics in brain tissue. Measurements of tyrosine hydroxylase immunoreactivity suggest that BDNF and NT-4 (presumably through their TrkB receptor) reduce the synthesis of this rate-limiting enzyme for dopamine synthesis in rescued as well as in normal neurons. In sharp contrast, survival-promoting doses of NT-3 (presumably through its TrkC receptor) maintained normal levels of tyrosine hydroxylase immunoreactivity in the rescued nigrostriatal neurons. These results suggest that for these adult central nervous system neurons, some neurotrophic factors are predominantly involved in facilitating cell survival, whereas others are more involved in regulating neurotransmitter function. (C) 1998 Academic Press.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 45 条
  • [1] Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections
    Alexi, T
    Hefti, F
    [J]. NEUROSCIENCE, 1996, 72 (04) : 911 - 921
  • [2] ALTAR CA, 1994, J NEUROCHEM, V63, P1021
  • [3] BRAIN-DERIVED NEUROTROPHIC FACTOR AUGMENTS ROTATIONAL BEHAVIOR AND NIGROSTRIATAL DOPAMINE TURNOVER INVIVO
    ALTAR, CA
    BOYLAN, CB
    JACKSON, C
    HERSHENSON, S
    MILLER, J
    WIEGAND, SJ
    LINDSAY, RM
    HYMAN, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11347 - 11351
  • [4] THE NEUROTROPHINS NT-4/5 AND BDNF AUGMENT SEROTONIN, DOPAMINE, AND GABAERGIC SYSTEMS DURING BEHAVIORALLY EFFECTIVE INFUSIONS TO THE SUBSTANTIA-NIGRA
    ALTAR, CA
    BOYLAN, CB
    FRITSCHE, M
    JACKSON, C
    HYMAN, C
    LINDSAY, RM
    [J]. EXPERIMENTAL NEUROLOGY, 1994, 130 (01) : 31 - 40
  • [5] IN-SITU HYBRIDIZATION OF TRKB AND TRKC RECEPTOR MESSENGER-RNA IN RAT FOREBRAIN AND ASSOCIATION WITH HIGH-AFFINITY BINDING OF [I-125] BDNF, [I-125] NT-4/5 AND [I-125] NT-3
    ALTAR, CA
    SIUCIAK, JA
    WRIGHT, P
    IP, NY
    LINDSAY, RM
    WIEGAND, SJ
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (09) : 1389 - 1405
  • [6] DIFFERENTIAL DISTRIBUTION OF EXOGENOUS BDNF, NGF, AND NT-3 IN THE BRAIN CORRESPONDS TO THE RELATIVE ABUNDANCE AND DISTRIBUTION OF HIGH-AFFINITY AND LOW-AFFINITY NEUROTROPHIN RECEPTORS
    ANDERSON, KD
    ALDERSON, RF
    ALTAR, CA
    DISTEFANO, PS
    CORCORAN, TL
    LINDSAY, RM
    WIEGAND, SJ
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 357 (02) : 296 - 317
  • [7] [Anonymous], 1984, HDB CHEM NEUROANATOM
  • [8] [Anonymous], NEURONAL PLASTICITY
  • [9] MESENCEPHALIC DOPAMINERGIC-NEURONS PROTECTED BY GDNF FROM AXOTOMY-INDUCED DEGENERATION IN THE ADULT BRAIN
    BECK, KD
    VALVERDE, J
    ALEXI, T
    POULSEN, K
    MOFFAT, B
    VANDLEN, RA
    ROSENTHAL, A
    HEFTI, F
    [J]. NATURE, 1995, 373 (6512) : 339 - 341
  • [10] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR SUPPORTS SURVIVAL OF INJURED MIDBRAIN DOPAMINERGIC-NEURONS
    BOWENKAMP, KE
    HOFFMAN, AF
    GERHARDT, GA
    HENRY, MA
    BIDDLE, PT
    HOFFER, BJ
    GRANHOLM, ACE
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 355 (04) : 479 - 489